|
|
The Evolving Era of Biologics to Improve Itching in Atopic Dermatitis
|
|
Facebook
LinkedIn
E-Mail
|
(3551)
|
Released: 03/15/2024
Expires: 03/31/2025 (subject to change)
- CE for this activity will not be available after this date.
Overview
Atopic dermatitis (AD) is the most common inflammatory skin disease worldwide. Despite being predominantly diagnosed in childhood (~80% of total cases), the prevalence of AD has been increasing in both children and adults consistently over the past several decades. When asked directly, more than 90% of AD patients report their itch as annoying or bothersome, even if they don’t voluntarily self-report the issue. This activity will inform and empower NPs to optimize the treatment plan using precision medicine and improve their patients' quality of life and health outcomes.
Objectives - Examine the patient-centric burden and clinical gravity of atopic dermatitis (AD), emphasizing the impact of itch and associated sleep interruption on health-related quality of life.
- Identify the complex pathophysiology and heterogeneous clinical manifestations of AD, focusing on treatment implications and emerging pharmacologic targets.
- Evaluate the evolving clinical trial evidentiary base for emerging biologic agents in treating AD, highlighting the therapeutic potential of targeting inflammatory and itch pathways.
- Develop evidence-driven, individualized treatment plans for patients with moderate-to-severe AD that integrate novel monoclonal antibodies into the calculus.
Speakers
Leigh Ann Pansch, MSN, FNP-BC, DCNP
Stephanie Simmerman, DNP, APRN
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.The speakers have the following disclosures: - Leigh Anne Pansch
- Speaker Bureau: Abbvie, Pfizer, Sanofi-Regeneron (AD); Arcutis, BMS, Dermavant, Johnson & Johnson, Eli Lilly, UCB (PSO); Biersdorf (dry skin); Galderma (acne/rosacea); Novartis (HS); Eli Lilly (PSA/AA); Sanofi/Regeneron (PN); Johnson & Johnson (PSA)
- Consultant: Leo (AD)
- Stephanie Simmerman
- Speaker Bureau: Abbvie, Dermavant, Arcutis (PSO), Sanofi-Regeneron (AD)
- Consultant: Heliocare (UV Light)
All relevant financial relationships have been mitigated.All Planners involved in this activity have no relevant financial relationships to disclose.This activity is supported by an educational grant from Galderma.
Activity Accreditation
This activity is approved for 1.50 contact hours of continuing education (which includes 0.50 hours of pharmacology) by the American Association of Nurse Practitioners®. Activity ID #24026544. This activity was planned in accordance with AANP Accreditation Standards and Policies. For those seeking CME credit, this activity is also available on epocrates® with AAFP CME credit. Click here to view this course on epocrates.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the post-test.
- Submit the evaluation to receive continuing education credit (CE/Rx).
- Click the "Get Certificate" button at the bottom of the screen when it is available. This will display your certificate of completion for printing/downloading and will also email a copy of the certificate to you.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1 Contact Hour(s) of CE,
0.5 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
